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Abstract
Background: The Programme for the Awareness and Elimination of Diarrhoea (PAED) was a pilot comprehensive
diarrhoea prevention and control programme aimed to reduce post-neonatal, all-cause under-five mortality by 15 %
in Lusaka Province. Interventions included introduction of the rotavirus vaccine, improved clinical case management
of diarrhoea, and a comprehensive community prevention and advocacy campaign on hand washing with soap,
exclusive breastfeeding up to 6 months of age, and the use of ORS and Zinc. This study aimed to assess the impact
of PAED on under-5 mortality.
Methods: The study was a pre-post evaluation design. The Demographic and Health Survey style population-based
two-stage approach was used to collect data at the beginning of the intervention and 3 years following the start of
intervention implementation in Lusaka province. The primary outcome of interest was an all-cause, post-neonatal
under-five mortality rate defined as the probability of dying after the 28th day and before the fifth birthday among
children aged 1–59 months. The Kaplan-Meier time to event analysis was used to estimate the probability of death;
multiplying this probability by 1000 to yield the post-neonatal mortality rate. Survival-time inverse probability
weighting model was used to estimate Average Treatment Effect (ATE).
Results: The percentage of children under age 5 who had diarrhoea in the last 2 weeks preceding the survey
declined from 15.8 % (95 % CI: 15.2 %, 16.4 %) in 2012 to 12.7 % (95 % CI: 12.3 %, 13.2 %) in 2015. Over the same
period, mortality in post-neonatal children under 5 years of age declined by 34 %, from an estimated rate of 29
deaths per 1000 live births (95 % CI: (26, 32) death per 1000 live births) to 19 deaths per 1000 live births (95 % CI:
(16, 21) death per 1000 live births). When every child in the population of children aged 1–59 months is exposed to
the intervention, the average time-to-death was estimated to be about 8 months more than when no child is
exposed (ATE = 7.9; 95 % CI: 4.4,11.5; P < 0.001).
Conclusion: Well-packaged diarrhoea preventive and treatment interventions delivered at the clinic and
community-level could potentially reduce probability of death among children aged 1–59 months.
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Background
In 2015, the global number of deaths among children
under the age of 5 years (U5) was estimated as 5.95
million of which 3.26 million occurred in children aged
1–59 months [1]. Diarrhoea remains the second-leading
cause of death among post-neonatal, under-five children,
with 558,000 estimated diarrhoeal deaths, globally [2].
Rotavirus infection is the largest single cause of diarrhoea
in children under 5, particularly of the severe diarrhoeal
cases resulting in dehydration that lead to hospitalisation
and death [3].
In 2015 in Zambia, an estimated 39,000 live-born
children died before their fifth birthday, of which 26,000
occurred among post-neonatal under-five children [1].
Approximately 16 % of Zambian children U5 experience
episodes of diarrhoea and about 66 % of these cases in-
volve at least one health facility visit for diarrhoea [4].
Although rotavirus-associated diarrhoea can be pre-
vented with rotavirus vaccine and can be treated with
low-osmolarity oral rehydration salt (ORS) and zinc, a
lack of awareness of effective strategies and preparedness
for diarrhoea prevention and management leads to late
presentation of ill children to the clinic and poor adher-
ence to prescribed interventions. Efficacy trials of rota-
virus vaccine have shown significant regional variability
[5–8], and effectiveness data on comprehensive diarrhoea
programmes in sub-Saharan Africa are largely unavailable.
In response, the Centre for Infectious Disease Research
in Zambia (CIDRZ) and the UK-based charity Ark, in col-
laboration with the Zambian Ministry of Health (MOH)
and other international stakeholders, developed and rolled
out the Programme for the Awareness and Elimination of
Diarrhoea (PAED), a demonstration pilot of comprehen-
sive diarrhoea control within Lusaka Province in 2012.
The goal of the PAED programme was to reduce all-cause
U5 mortality by 15 %, as has been described elsewhere [9].
We hypothesised that an increase in effective diarrhoea
prevention and treatment intervention coverage would de-
crease diarrhoea-associated morbidity and in turn de-
crease diarrhoea-associated mortality. The projected
intervention impact was derived using the Lives Saved
Tool (LiST) [10] under a number of assumptions on inter-
vention components of the PAED programme including:
rotavirus vaccination – from 0 to 90 % coverage with a
24 % mortality reduction; hand washing with soap – from
20 to 30 % coverage with a 48 % mortality reduction; ex-
clusive breastfeeding promotion – from 15 to 35 to 65 %
coverage and 3.5 fold risk reduction; and low-osmolarity
ORS – from 53 to 75 % coverage with a 93 % mortality re-
duction; and zinc – from <5 to 40 % coverage with a 23 %
mortality reduction [9]. The PAED was implemented from
January 2012 – October 2014.
We elected to target post-neonatal mortality reduction
because our interventions promise little or no effect to
reduce neonatal mortality. Mortality reduction in the
neonatal age-band has lagged behind gains achieved in
the general under-5 population; about 44 % of all under-
5 mortality happens within the first 28 days; this propor-
tion is increasing as child deaths in the post neonatal
age-band reduce [1, 11, 12].
In this paper, we present the evaluation of the programme
through two rounds of household population-based
surveys undertaken 3 years apart.
Methods
Study setting
At the time of the baseline study, Lusaka Province had
four geographical districts: Lusaka, Kafue, Chongwe, and
Luangwa. The four districts cover an area of 21,896 km2
and an estimated population of nearly 2.2 million [13].
There are just under 85,000 births a year in this province
and more than 320,000 children under 5 years of age [13].
Intervention
The PAED began in the four districts of Lusaka Province
in early 2012. The PAED was designed to focus on three
key project areas: i) rotavirus vaccination of approxi-
mately 180,000 infants, ii) a comprehensive community
prevention and advocacy campaign, and iii) hands-on,
procedural training of 560 first-responder clinicians in
all 100 government health centres within the province.
PAED was fully integrated into the government’s Ex-
panded Programme on Immunisations and supported the
establishment of cold chain, logistics and systems moni-
toring (e.g. vaccine and supply chain management) for the
delivery of vaccines. The community prevention campaign
communicated the benefits of hand washing with soap,
and exclusive breastfeeding for diarrhoea prevention, as
well as advocated for the rotavirus vaccine, and improved
case management using low-osmolarity ORS and zinc for
diarrhoea treatment.
Sample size consideration
A post-neonatal under-five mortality rate of 23 deaths
per 1000 live births was assumed for Lusaka Province
based on the 2008 Zambia demographic health survey
data. For each round of survey, a total of 21,956 house-
holds were required at 10 % precision and an estimated
17.2 % of under-five children constituting the Zambian
population for an average household size of 5 with a
nonresponse rate of 0.8 % and a design effect of 1.15.
The national Central Statistical Office (CSO) has admin-
istratively divided the country into Census Supervisory
Areas (CSAs). For a decision of 100 households to be
selected per CSA, this translated into 220 CSAs selected
in each round of survey. At baseline 100 households per
CSA were sampled, while at endline, 125 households per
CSA were sampled.
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Evaluation design
The study was a pre-post evaluation design. Baseline data
on primary outcome and potential confounders were col-
lected at the beginning of the programme in 2012. Endline
data was collected 3 years following the implementation
of the intervention in 2015 using similar survey design.
Samples
A two-stage stratified random sampling design was used
to sample households. Lusaka Province was stratified in 4
districts. The first stage was the ‘probability proportional
to size’ selection of the CSAs in each district (stratum).
The households in the selected CSAs constituted the sec-
ondary sampling units in the second stage of the sampling
design. The allocation of CSAs was based on population
density to include 80 % of the CSAs from the predomin-
antly urban Lusaka District and 20 % of the CSAs from
the other three more rural districts. A household was
defined as a group of one or more related or unrelated
people who share the same cooking and eating facilities
and have one person who is regarded as the head of
household, consistent with the CSO definition [4].
Surveyors sampled households by canvassing the CSA
to visually identify the CSA boundaries defined by maps
obtained from the CSO. They would then determine the
approximate centre of the CSA and use a “spin of a bottle”
method to determine the initial sampling direction. They
approached every third household using a spiral or linear
(spokes of a wheel) approach, depending on the household
density in the CSA. When surveyors arrived at a sampled
household, they asked for the person who normally makes
day-to-day decisions regarding care of the children and the
household. This ‘manager’ of the household could be either
male or female, but priority was given to females, as they
are generally believed to be more knowledgeable about the
health status of all family members. The household man-
ager was eligible to enrol their household if they signed/
thumb printed an informed consent form and were either
an adult 18 years or older, or were a young woman
15–17 years who was married, pregnant, or had been
pregnant. If no head of household was available, the
interviewer returned up to three more times. These
return visits usually took place either the same day or
the following day. If follow-up visits remained unsuc-
cessful, an eligible household that was most near the
household was selected as a replacement household.
The Informed Consent Forms (ICFs) were multi-lingual
and written in four major Zambian languages. In cases
where a potential participant was illiterate an impartial
literate witness was engaged.
Data collection
Data collection tools were adapted from a set of standard
DHS programme questionnaires that have been used in
many countries worldwide (http://dhsprogram.com/What-
We-Do/Survey-Types/DHS-Questionnaires.cfm). A House-
hold Questionnaire was used to collect information on
characteristics of the household’s dwelling unit and charac-
teristics of usual residents and visitors. It was also used to
identify members of the household who were eligible for an
individual interview. All eligible women aged 18–49 who
had been members of the household for equal to or greater
than 1 month were asked to provide a birth history and
answer questions about their children using a women ques-
tionnaire. Women who were 15–17 years old, who were
married, pregnant, or who had ever been pregnant and
who had lived in the household for at least 1 month were
also asked to provide a birth history. All women ever
reporting pregnancy were included to avoid misclassifi-
cation of stillbirth.
The survey questionnaires were programmed in an
Open Data Kit (ODK) tablet platform and optimised for
survey administration using Nexus 7 2013 tablets. Weekly
quality assurance/quality control was performed to
generate queries, which were sent to field staff to effect
necessary corrections and feedback into the system.
Definitions
To optimise objective collection of data, the following
field definitions were applied:
 Diarrhoea: Reported 3 or more bouts of watery
stools within a 24-hour period experienced within
two weeks of the survey.
 Hand washing with soap: A mother reporting that
soap is used when washing hands and the surveyors
physically confirming availability of soap at the usual
hand washing place within the household.
 ORS and zinc availability: Reported use of the drug and
physical verification of the drug or sachet availability
within the house at the time of the interview.
Rotavirus vaccination: Reported eligible infants in the
household immunised and the surveyor verifying the
record on the child’s under 5 card.
Statistical analysis
The primary outcome of interest was a post-neonatal
under-five mortality rate defined as the probability of
dying after the 28th day and before the fifth birthday
among children aged 1–59 months. Every child recorded
in the complete birth history dataset who was born within
5 years preceding each round of survey was included. For
each round of survey, the Kaplan-Meier failure method
was used to estimate the probability of death; multiplying
the probability of death by 1000 gives the post-neonatal
mortality rate expressed as deaths per 1000 live births. A
child becomes at risk of death after 28 days following
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birth. The log rank test was used to compare the survival
curves for the two rounds of surveys. Birth history data is
suitable because it recorded the three key variables of sur-
vival data: date of birth of child, date of death of child (or
age at death), and event status - death or alive.
Diarrhoea prevalence was computed as the proportion
of U5 children who had diarrhoea in the two weeks prior
to the survey. Coverage of key intervention components
such as rotavirus vaccination, hand washing with soap as
well as availability of ORS and zinc in households were
also estimated to determine the level of penetration of
the intervention.
Since the evaluation design was a nonrandomised-
controlled trial we elected survival-time inverse-probability
weighting regression adjustment (IPWRA) model to esti-
mate ‘Average Treatment Effect’ (ATE), adjusting for poten-
tial confounders. We specified the treatment variable
(i.e. pre-post intervention) as a logit function of a measure
of ‘penetration’ of key intervention components (i.e. avail-
ability of ORS, zinc in the household, and Hand-washing
with soap); the time to censoring was modelled as a
Weibul function of sex of child and maternal age, while
the outcome model was specified as Weibul with sex of
child, maternal age, and diarrhoea incidence as covariates.
The treatment effects models are efficient in strengthening
the results of observational studies by using the potential
outcome (counterfactual) framework.
The model has three assumptions. First, it requires the
potential outcomes to be independent of the treatment
assignment after conditioning on the covariates. Given
that the intervention was not randomly assigned we
elected to ensure this assumption by conditioning on
key confounding variables in the model. Second, it re-
quires that each individual in the study area have sufficient
positive probability of being assigned to each treatment
group. We investigated this assumption using a diagnostic
approach in which we estimated the probabilities of treat-
ment (i.e. propensity score) and compared its balance be-
tween covariates. Third, the model also requires correct
adjustment for censoring - we accounted for censoring in
the estimation of the ATE using Weilbul specification in
the IPWRA model.
The analyses were performed using Stata version 14
(StatCorp, College Station, Texas, USA).
Results
A total of 46,464 households were surveyed in the two
rounds of surveys: 22,217 at baseline, pre-intervention;
and 24,247 at endline, post-intervention. These house-
holds accommodated 16,455 children aged 1–59 months
at pre-intervention and 20,447 at post-intervention. Re-
ported deaths among children aged 1–59 months were
estimated as 362 in 2012 and 259 in 2015 (Fig. 1). The
distribution of sex of child and mother’s age at birth was
similar across intervention phases (Table 1).
Between 2012 and 2015, hand washing with soap (soap
visible to the interviewer) increased by about 19 %;
availability of ORS in households for treating diar-
rhoea increased by about 66 %; and availability of zinc
in households for treating diarrhoea increased by about
3 %; and in 2015 the coverage of under 5 card-confirmed
rotavirus vaccination was estimated as 87 %; (Table 2).
The percentage of children under age 5 who had diar-
rhoea in the last 2 weeks preceding the survey declined
from 15.8 % (95 % CI: 15.2 %, 16.4 %) in 2012 to 12.7 %
(95 % CI: 12.3 %, 13.2 %) in 2015 (Table 1). Over the same
Fig. 1 Flow of participants in the two rounds of surveys, 2012 to 2015,
Lusaka Province, Zambia
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period, mortality in post-neonatal children under 5 years of
age declined by 34 %; from an estimated rate of 29 deaths
per 1000 live births (95 % CI: [26, 32] death per 1000 live
births) to 19 deaths per 1000 live births (95 % CI: [16, 21]
death per 1000 live births) (Fig. 2). When every child in the
population of children aged 1–59 months is exposed to the
intervention, the average time-to-death was estimated
to be about 8 months more than when no child is ex-
posed (ATE = 7.9; 95 % CI: 4.4,11.5; P < 0.001) (Table 3).
Discussion
The results showed a 34 % reduction in the probability
of death among U5 children who had survived beyond 1
month, over the period of implementation of PAED from
2012 to 2015. That is, in 2015, 1 in every 52 children born
in Lusaka Province, who had survived the first 28 days,
will die before attaining 5 years of age; as compared to 1
in every 34 children recorded at the start of the interven-
tion. The results also showed that diarrhoeal prevalence
declined by about 20 % over the same period.
Our findings are consistent with the general trend as
reported in the Zambia Demographic and Health surveys
from 85 post neonatal under-5 deaths per 1000 live births
in 2007 to an estimated 51 deaths per 1000 live births in
2013 [4]. Given that the trends are similar and we did not
have a contemporaneous control arm, we cannot attribute
the mortality reduction to our intervention. Nonetheless,
these results suggest that diarrhoea preventive inter-
ventions may contribute to substantial reduction in
deaths among post-neonatal U5 children. Hand wash-
ing interventions have been shown to yield an esti-
mated 32 % reduction in diarrhoea episodes in children
living in low- or middle-income countries (IRR = 0.68,
95 % CI 0.52 to 0.90; 4 trials) [14, 15], whereas rota-
virus vaccine prevented severe rotavirus episodes by
about 50 % in sub-Saharan Africa [16]. Similarly, diar-
rhoea treatment interventions such as zinc and ORS
have been estimated to reduce diarrhoea deaths by
23 % [10] and 93 % [17], respectively. In our study, we
found that the coverage of the rotavirus vaccination
among children aged 12–23 months was 87 %, while
that of hand washing with soap and low osmolarity
ORS were 88 and 87 % respectively. Use of zinc to treat
diarrhoea was estimated to be about 11 % in this study.
Table 1 Background characteristics of children aged 1–59 months, Lusaka province, Zambia
Characteristics Pre-intervention (2012) Post-intervention (2015) Total
Number of children (% of total)
n = 16,455
Number of children (% of total)
n = 20,447
Number of children (% of total)
n = 36,902
Sex of child
Male 7,885 (47.9) 10,115 (49.5) 18,000 (48.8)
Female 8,135 (49.4) 10,332 (50.5) 18,467 (50.0)
Mother’s age at birth
<20 2,930 (17.8) 3,960 (19.4) 6,890 (18.7)
20–34 11,988 (72.9) 14,599 (71.4) 26,587 (72.1)
35–49 1,448 (8.8) 1,838 (9.0) 3,286 (8.9)
Missing
Districts
Lusaka 13,428 (81.6) 14,864 (72.7) 28,292 (76.7)
Kafue 1,416 (8.6) 2,669 (13.1) 4,085 (11.1)
Chongwe 1,440 (8.8) 2,098 (10.3) 3,538 (9.6)
Luangwa 141 (0.9) 213 (1.0) 354 (1.0)
Diarrhoea prevalence 2,457 (15.8) 2,484 (12.7) 4,941 (14.2)
Table 2 Coverage (%) of interventions in Lusaka province, Zambia, 2012–2015
Interventions 2012 2015 % increase from baseline
Coverage (A) 95 % CI Coverage (B) 95 % CI [(B)-(A)]
Rotavirus vaccination (2 doses)a - 86.7 [82.4,90.1] -
Hand washing with soap (visible) 69.5 [66.9,72.1] 88.4 [87.0,89.7] 18.9
Low-osmolarity ORS 21.7 [19.4,24.1] 87.4 [86.0,88.7] 65.7
Zinc 7.8 [6.4,9.5] 11.2 [9.5,13.1] 3.4
aNational rotavirus vaccination was introduced in November 2013, pilot introduction in January 2012
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This is consistent with other findings that demon-
strated that availability of zinc in Zambia was still poor
with only about 10 % of the needed supply available in
Zambia in 2012 [18].
Even with all the potential gains of the PAED interven-
tions, there remain multiple gaps and challenges. Whereas
the vaccination programme has been scaled-up nationally,
vaccine coverage needs to be enhanced at national level for
maximum population benefits. ORS and zinc coverage in
the public sector remain low [18]. Taking the promotion of
hand washing with soap and exclusive breastfeeding to
national scale will also require well-funded dedicated
programmes. Another gap based on the UNICEF-WHO
recommended six-point strategy for diarrhoea control
is access to safe drinking water and sanitation [19]. Up-
grading and providing improved sanitation facilities for
the 56 % of Zambians without access to improved sani-
tation facilities [4] could improve hygiene and thereby
result in reduced diarrhoea episodes.
Nonetheless, our findings are very encouraging as they
show a greater than double mortality reduction as planned
by PAED (34 % vs. 15 %), acknowledging the downward
trend nationwide. However, there are several limitations
to these findings: We recognise methodological challenges
limiting our temporal alignment between the behaviour
change due to the intervention and post-neonatal U5
mortality. For example, the estimation of the intervention
penetration was immediate – i.e. availability of ORS and
zinc in the household, and hand washing with soap. A
woman’s behaviour may not have changed when the baby
died months before. As stated earlier, the best epidemio-
logical design should have been a cluster randomized
controlled (RCT) study design; but for national scale-up
of proved interventions, we could not undertake a formal
RCT. Second, the study was not powered to estimate the
impact of the intervention in terms of diarrhoea cause-
specific mortality. Lastly, by design our mortality data is
based on recall by individuals, which has its own limitations
Fig. 2 Kaplan Meier failure estimates (mortality per 1000 livebirths) Pre- Post-intervention among post-neonatal under-five children, Lusaka
province, Zambia
Table 3 Average treatment effect (ATE) on time-to-death among
children aged 1–59 months, 2012–2015, Lusaka Province, Zambia
Effects Coefficienta 95 % CI P-value
ATE
Pre-intervention ref
Post-intervention 7.9 [4.4,11.5] <0.001
Potential Outcome Mean
Pre-intervention 9.4 [6.8,12.0] <0.001
Relative ratio 0.85 [0.27,1.42] <0.01
aSurvival treatment effect estimation model (Estimator: inverse-probability
weight regression adjustment; Outcome model: Weibul; Treatment model:
logit; Censoring model: Weibul)
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[4, 20–22]. Given that this is not a controlled study, there
may be some important biases - the lack of a control group
means that history effects (extraneous events) and contem-
poraneous trends are an important threat to validity.
Despite these limitations and challenges, there is evi-
dence to suggest that targeting a major contributor to
child deaths such as diarrhoea may yield important
gains in reduced child mortality.
Conclusion
Well-packaged diarrhoea preventive and treatment inter-
ventions delivered at the community and health facility
levels may contribute to reductions in neonatal under-five
mortality. Further efforts are required to take such im-
pactful interventions to scale and sustain them.
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